TGFB1 and cancer: Those findings suggest that circulating TGF-β levels are associated with not only tumor biology but also systemic host response to tumors, which precedes clinical diagnosis, and thus that TGF-β, antigens emanating from tumors, and autoantibodies against tumor antigens are potential biomarkers for early detection of cancer.